6 years ago

Echopoint Medical Secures £2.8 Million Funding for Innovative Medtech Solution

  • Echopoint Medical, a UK-based medtech company, raised £2.8 million in funding

  • The investment came from Parkwalk, the UCL Technology Fund, and two grants from Innovate UK

  • Echopoint Medical's technology aims to help coronary heart disease patients in a 'grey zone' where the need for treatment is unclear

  • Their microcatheters use fiber-optic sensors to accurately measure blood pressure and flow, enabling clinicians to assess patients and potentially reduce stent implants

  • The funding will be used to further develop the company's microcatheters and technology platform.

      • ProblemHealthcare

      "For coronary heart disease patients in the 'grey zone' where the need for treatment is unclear, there's no way to accurately measure blood pressure and flow to determine the best course of action. This leads to unnecessary stent implants and puts patients at risk."

      Solution

      "Echopoint Medical has developed microcatheters that use fibre-optic sensors to accurately measure blood pressure and flow, providing clinicians with precise data to assess patients and minimize the need for invasive procedures like stent implants."

      Covered on